DC Chemicals

All products / DC11366

HKI 357
CAT. NO. DC11366

HKI 357

Pack sizes and prices

Pack sizePrice
100 mg$550 USDRequest a quote →
250 mg$1,100 USDRequest a quote →
1 g$2,200 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

HKI 357 is an irreversible dual inhibitor of the EGF receptor tyrosine kinases EGFR and HER2 (IC50s = 34 and 33 nM, respectively). It inhibits proliferation of A431, SK-BR-3, and SW620 cancer cell lines (IC50s = 120, 2.5, and 511 nM, respectively). HKI 357 suppresses EGFR autophosphorylation and phosphorylation of the downstream effectors AKT and ERK in the gefitinib-susceptible and -resistant cell lines NCI-H1650 and NCI-H1650(G7), respectively.In vivo, HKI 357 (10 mg/kg) inhibits tumor growth in BT474, A431, and SUM190 mouse xenograft models.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC11366
Product nameHKI 357
CAS848133-17-5
Molecular formulaC31H29ClFN5O3
Molecular weight574.053
Purity>98%
SMILESO=C(/C=C/CN(C)C)N([H])C1=C(OCC)C=C(N=CC(C#N)=C2N([H])C3=CC=C(OCC4=CC=CC(F)=C4)C(Cl)=C3)C2=C1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — HKI 357 (DC11366)

Related research products